Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Autoimmune hyperchylomicronemia].

S Nozaki1, Y Matsuzawa

  • 1Kawanishi General Hospital.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|January 19, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oral hygiene care for critically ill children to prevent ventilator-associated pneumonia: a systematic review and meta-analysis.

The Journal of hospital infection·2025
Same author

Search for Gamma-Ray Spectral Lines from Dark Matter Annihilation up to 100 TeV toward the Galactic Center with MAGIC.

Physical review letters·2023
Same author

Constraints on Cosmic Strings Using Data from the Third Advanced LIGO-Virgo Observing Run.

Physical review letters·2021
Same author

Bounds on Lorentz Invariance Violation from MAGIC Observation of GRB 190114C.

Physical review letters·2020
Same author

Dietary fish, n-3 polyunsaturated fatty acid consumption, and depression risk in Japan: a population-based prospective cohort study.

Translational psychiatry·2017
Same author

Acute decrease in the stiffness of resting muscle belly due to static stretching.

Scandinavian journal of medicine & science in sports·2015
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

Autoimmune hyperlipidemia involves autoantibodies attacking lipoproteins. This study details cases of autoimmune hyperchylomicronemia and hyperlipidemia, suggesting broader screening for nonfamilial cases, especially with autoimmune conditions.

Area of Science:

  • Immunology
  • Metabolic Disorders
  • Lipid Metabolism

Background:

  • Autoimmune hyperlipidemia is a rare condition where the immune system mistakenly targets lipoproteins or related enzymes.
  • Previous research has documented cases, but the underlying mechanisms are often unclear.

Observation:

  • A patient presented with autoimmune hyperchylomicronemia caused by autoantibodies against lipoprotein lipase and hepatic triglyceride lipase.
  • Another hyperlipidemic patient had inhibitory monoclonal antibodies affecting low-density lipoprotein binding, linked to multiple myeloma.

Findings:

  • The study identifies specific autoantibodies responsible for disrupting normal lipoprotein metabolism in hyperlipidemic patients.
  • These findings highlight distinct autoimmune mechanisms contributing to severe lipid disorders.

Related Experiment Videos

Implications:

  • Screening for autoimmune hyperlipidemia should be considered in patients with nonfamilial hyperlipidemia, particularly those with co-existing autoimmune diseases.
  • Identifying such cases can lead to a better understanding of autoimmune-mediated metabolic diseases and potentially new therapeutic targets.